
Newomics, a US-based biotech firm, innovates personalized healthcare solutions using proprietary silicon-microfluidic-chip technology.
newomics.comCrawled Oct 16, 2026
The Newomics DuoESI Source provides two sources for the price of one. Interchangeable interface modules for nanoflow and microflow take only minutes to swap.
The Flow Splitting Kit has configurations for integrating the Newomics MnESI source and M3 multinozzle emitters into analytical LC-MS workflows.
The Inlet Pump Kit is an injection pump kit that enables the novel PCI (post-column inlet) function of Newomics MEA Chips.
The Newomics MEA chip is the best plug-and-play mass spectrometry solution for achieving both superior nanoflow and microflow in LC-MS applications.
Newomics has signed an exclusive license agreement with The University of California through Lawrence Berkeley National Laboratory to commercialize M3 emitters and MEA chips.
Newomics will launch its first product line, Newomics M3 emitters, and present three scientific posters on its platforms and solutions at the 65th ASMS Conference, June 4–8, 2017, in Indianapolis, IN.
Newomics publishes a new solution for drug discovery and drug target discovery in ACS Chemical Biology, entitled: “Proteoform-Specific Protein Binding of Small Molecules in Complex Matrices”.
The company offers a workplace that values personal contributions, creativity, participation, commitment, inclusion, and respect.
Newomics Inc. 2612 8th Street Berkeley, CA 94710
Newomics products guarantee high sensitivity, high throughput, robustness, and plug-and-play design. High-performance devices for LC-MS.
Newomics Inc. operates the www.newomics.com website and describes its policies for collecting, using, and disclosing personal data, along with users’ related choices.